Hologic (HOLX) Tops Q3 EPS by 37c, Revenues Beat; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Hologic Announces Financial Results for Third Quarter of Fiscal 2020
July 29, 2020 4:01 PM EDTRevenue of $822.9 Million Declines 3.5% due to Cynosure Divestiture, 3.1% in Constant Currency
Organic Revenue Increases 7.7%, 8.1% in Constant Currency, as Strong Sales of COVID Tests Offset Declines in Other Businesses
Company Posts GAAP Diluted EPS of $0.53, Non-GAAP Diluted EPS of $0.75
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal third quarter ended June 27, 2020.
Our strong third quarter financial results reflect the incredible contributions the Hologic team is making in the fight against the... More



